Patterns of improvement following initial response in patients treated with naxitamab for relapsed/refractory high-risk neuroblastoma

被引：0
|
作者：
Mora, Jaume
Chan, Godfrey C.
Morgenstern, Daniel A.
Amoroso, Loredana
Nysom, Karsten
Faber, Joerg
Wingerter, Arthur
Bear, Melissa
Rubio-San-Simon, Alba
Tornoe, Karen
Duering, Maria
Kushner, Brian H.
机构：
[1] Hosp St Joan de Deu, Pediat Canc Ctr Barcelona, Barcelona, Spain
[2] Queen Mary Hosp, Hong Kong, Peoples R China
[3] Univ Hong Kong, Hong Kong Childrens Hosp, Pokfulam, Hong Kong, Peoples R China
[4] Hosp Sick Children, Toronto, ON, Canada
[5] IRCCS Ist Giannina Gaslini, Genoa, Italy
[6] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[7] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Pediat & Adolescent Med, Mainz, Germany
[8] Riley Hosp Children, Indianapolis, IN USA
[9] Hosp Infantil Univ Nino Jesus, Madrid, Spain
[10] Y mAbs AS, Horsholm, Denmark
[11] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10033
引用
收藏
页数：1
相关论文
共 50 条
  • [31] EFFICACY OF NAXITMAB IN REFRACTORY HIGH-RISK NEUROBLASTOMA
    Mora, Jaume
    Chan, Godfrey Chi Fung
    Morgenstern, Daniel
    Amoroso, Loredana
    Nysom, Karsten
    Faber, Joerg
    Wingerter, Arthur
    Bear, Melissa
    Rubio San Simon, Alba
    Kushner, Brian
    Tornoe, Karen
    Christensen, Rene
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [32] International, Multicenter Phase II Trial With Humanized Anti-GD2 Monoclonal Antibody Naxitamab for Treatment of Refractory/Relapsed High-Risk Neuroblastoma: Efficacy and Safety Data
    Mora, J.
    Chan, G.
    Morgenstern, D.
    Nysom, K.
    Bear, M.
    Dalby, L. W.
    Lisby, S.
    Kushner, B.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S294 - S294
  • [33] Intraoperative Radiation Therapy for Relapsed or Refractory High-Risk Neuroblastoma: A 27-Year Experience
    Conte, Brianna
    Casey, Dana L.
    Tringale, Kathryn R.
    Honeyman, Joshua
    Narayan, Nicole J. C.
    Laquaglia, Michael P.
    Gerstle, Justin Ted
    Modak, Shakeel
    Kushner, Brian H.
    Kramer, Kim
    Wolden, Suzanne L.
    PRACTICAL RADIATION ONCOLOGY, 2024, 14 (03) : e226 - e232
  • [34] Retrospective analysis of relapsed abdominal high-risk neuroblastoma
    Duebbers, Martin
    Simon, Thorsten
    Berthold, Frank
    Fischer, Janina
    Volland, Ruth
    Hero, Barbara
    Cernaianu, Grigore
    JOURNAL OF PEDIATRIC SURGERY, 2018, 53 (03) : 558 - 566
  • [35] Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
    Klement, Piroska
    Fiedler, Walter
    Gabdoulline, Razif
    Dallmann, Louisa-Kristin
    Wienecke, Clara Philine
    Schiller, Johannes
    Kandziora, Christian
    Teich, Katrin
    Heida, Bennett
    Buttner, Konstantin
    Brandes, Maximilian
    Funke, Carolin
    Wichmann, Martin
    Othman, Basem
    Chromik, Joerg
    Amberg, Stefanie
    Kebenko, Maxim
    Schlipfenbacher, Vera
    Wilke, Anne Christine
    Modemann, Franziska
    Janning, Melanie
    Serve, Hubert
    Bokemeyer, Carsten
    Theile, Susann
    Deppermann, Ute
    Kranich, Anne L.
    Ganser, Arnold
    Thol, Felicitas
    Heuser, Michael
    ANNALS OF HEMATOLOGY, 2023, 102 (02) : 323 - 328
  • [36] Naxitamab Treatment of Refractory/Relapsed High-Risk Neuroblastoma (R/R HR NB); Subgroup Analysis of Updated Interim Efficacy and Safety Data for The Registrational Phase II Trial
    Mora, J.
    Bear, M.
    Chan, G. Chi-Fung
    Morgenstern, D.
    Nysom, K.
    Tornoe, K.
    Losic, N.
    Kushner, B.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S85 - S85
  • [37] Molecular Response Patterns in Relapsed/Refractory AML Patients Treated with Selinexor and Chemotherapy
    Klement, Piroska
    Fiedler, Walter
    Gabdoulline, Razif
    Dallmann, Louisa-Kristin
    Wienecke, Clara
    Schiller, Johannes
    Kandziora, Christian
    Teich, Katrin
    Heida, Bennet
    Brandes, Maximilian
    Funke, Carolin
    Wichmann, Martin
    Othman, Basem
    Chromik, Jorg
    Buettner, Konstantin
    Amberg, Stefanie
    Kebenko, Maxim
    Schlipfenbacher, Vera
    Wilke, Anne C.
    Modemann, Franziska
    Janning, Melanie
    Serve, Hubert
    Bokemeyer, Carsten
    Deppermann, Ute
    Kranich, Anne L.
    Ganser, Arnold
    Thol, Felicitas
    Heuser, Michael
    BLOOD, 2021, 138
  • [38] Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
    Piroska Klement
    Walter Fiedler
    Razif Gabdoulline
    Louisa-Kristin Dallmann
    Clara Philine Wienecke
    Johannes Schiller
    Christian Kandziora
    Katrin Teich
    Bennett Heida
    Konstantin Büttner
    Maximilian Brandes
    Carolin Funke
    Martin Wichmann
    Basem Othman
    Joerg Chromik
    Stefanie Amberg
    Maxim Kebenko
    Vera Schlipfenbacher
    Anne Christine Wilke
    Franziska Modemann
    Melanie Janning
    Hubert Serve
    Carsten Bokemeyer
    Susann Theile
    Ute Deppermann
    Anne L. Kranich
    Arnold Ganser
    Felicitas Thol
    Michael Heuser
    Annals of Hematology, 2023, 102 : 323 - 328
  • [39] Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor
    Lerman, Benjamin J.
    Li, Yimei
    Carlowicz, Cecilia
    Granger, Meaghan
    Cash, Thomas
    Sadanand, Arhanti
    Somers, Katherine
    Ranavaya, Aeesha
    Weiss, Brian D.
    Choe, Michelle
    Foster, Jennifer H.
    Pinto, Navin
    Morgenstern, Daniel A.
    Rafael, Margarida Simao
    Streby, Keri A.
    Zeno, Rachel N.
    Mody, Rajen
    Yazdani, Sahr
    Desai, Ami, V
    Macy, Margaret E.
    Shusterman, Suzanne
    Federico, Sara M.
    Bagatell, Rochelle
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 508 - +
  • [40] Treatment and Outcomes of Patients With Relapsed, High-Risk Neuroblastoma: Results of German Trials
    Simon, Thorsten
    Berthold, Frank
    Borkhardt, Arndt
    Kremens, Bernhard
    De Carolis, Boris
    Hero, Barbara
    PEDIATRIC BLOOD & CANCER, 2011, 56 (04) : 578 - 583
12345